Table 1. Biopsy results (n=1533) including control group crossed to Pap results (based on Bethesda 2001) and HPV results.
PAP cytology results
|
|||||||
---|---|---|---|---|---|---|---|
Biopsy | Normal | ASC-US | ASC-H | LSIL | HSIL | AGC | Total |
HPV− (n=626) | |||||||
AIS | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CIN3 | 0 | 1 | 0 | 0 | 0 | 0 | 1 |
CIN2 | 0 | 1 | 0 | 0 | 0 | 0 | 1 |
CIN1 | 11 | 39 | 1 | 7 | 0 | 0 | 58 |
Normal | 491 | 63 | 0 | 9 | 1 | 2 | 566 |
Total | 502 | 104 | 1 | 16 | 1 | 2 | |
HPV+ (n=907) | |||||||
AIS* | 0 | 1 | 0 | 0 | 0 | 2 | 3 |
CIN3 | 25 | 6 | 1 | 7 | 16 | 0 | 55 |
CIN2 | 9 | 2 | 2 | 3 | 6 | 0 | 22 |
CIN1 | 240 | 30 | 1 | 83 | 3 | 0 | 357 |
Normal | 393 | 24 | 1 | 50 | 2 | 0 | 470 |
Total | 667 | 63 | 5 | 143 | 27 | 2 |
ASC-US=atypical squamous cells of undetermined significance; ASC-H=atypical squamous cells: cannot exclude HSIL; LSIL=low-grade squamous intraepithelial lesion; HSIL=high-grade squamous intraepithelial lesion; AGC=atypical glandular cells.
*The three AIS (in situ adenocarcinoma) were found combined with HSIL (CIN3) lesions within each biopsy.